Selective CBP degrader FHT-171 shows strong anti-tumor activity and favorable tolerability in preclinical models of heavily pretreated ER+ breast cancer - Selective EP300 degrader outperforms clinical ...

Kyverna Therapeutics reported robust early Phase 2 miv-cel data in gMG, showing 100% response rates and deep, durable ...

Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases ...

Okay, first things first. Let’s not do the fake outrage thing here. Yes, the clip was awkward. Randy Arozarena’s postgame comments were spicy enough to light up the internet and make it slightly worse ...

Last year’s landmark case of “Baby KJ”—the first patient to receive a personalized CRISPR‑based gene therapy—showcased both the promise and the persistent challenges of genome editing. While CRISPR ...

Please provide your email address to receive an email when new articles are posted on . Optometrists should screen all patients for hypertension and offer education on the topic. If the blood pressure ...

While his days as an NFL quarterback are behind him, Tom Brady will once again throw passes in a competitive setting. The seven-time Super Bowl champion will join several current and former NFL stars ...

When Cody White found out he was going to make the Seahawks' 53-man roster to start the season, his first call was to his mother, Amy, and the two shared a cry while celebrating the accomplishment. "I ...

FGFRi are effective treatment strategies for patients with advanced solid tumors harboring FGFR alterations, with manageable toxicities in most patients. FGFRi are a safe and effective treatment ...